IP Litigation > Nova Content
PTAB Denies Party Submissions on Remanded IPR Appeal
A successful appeal to the Federal Circuit from the Patent Trial & Appeal Board (PTAB) typically ends in... Read More »
CASE OF THE WEEK
Oracle America, Inc. v. Google LLC, Appeal No. 2017-1118, -1202 (Fed. Cir. 2018)
In an appeal from a jury trial, the Federal Circuit reversed ... Read More »
New Director’s Interest in Predictability To Drive PTAB Change
As pointed out yesterday over at IPWatchdog, the USPTO Solicitor has withdrawn as Intervenor... Read More »
The PTAB ruled that the Saint Regis Mohawk Tribe could not assert sovereign immunity in IPRs of patents that Allergan had assigned to the Tribe relating to... Read More »
In In re: Power Integrations, Inc., [2017-1304] (March 19, 2018), the Federal Circuit reversed the decision on remand that claims 1, 17, 18, and 19 of U.S. Patent No. ... Read More »
In re Power Integrations, Inc., Appeal No. 17-1304 (Fed. Cir. 2018)
In In re: Power Integrations, Inc., the Federal Circuit reversed the Patent Trial and... Read More »
In DSS Technology Management, Inc. v. Apple Inc., [2016-2523, 2016-2524] (March 23, 2018), the Federal Circuit reversed the decision of the PTAB, finding claims... Read More »
Federal Circuit Summary
Before Moore, Reyna, and Taranto. Appeal from the Patent Trial and Appeal Board.
Summary: A party in an int er partes review... Read More »
The University of Minnesota (UMinn) and Toyota Motor Corp. (Toyota) co-own U.S. Patent 8,394,618 (the ’618 patent). After Reactive Surfaces Ltd. filed a... Read More »
CASE OF THE WEEK
SimpleAir, Inc. v. Google LLC, Appeal No. 2016-2738 (Fed. Cir. 2018)
In SimpleAir, Inc. v Google LLC, the Federal Circuit vacated a district... Read More »
Federal Circuit Summary
Before Dyk, Reyna, and Hughes. Appeal from the Patent Trial and Appeal Board
Summary: In an in ter partes review... Read More »
Ottah v. Fiat Chrysler, Appeal No. 2017-1842 (March 7, 2018)
In Ottah v. Fiat Chrysler, the Federal Circuit affirmed a district court’s grant of summary... Read More »
Preserving Access to Cost Effective Drugs (PACED) Act
Senator Tom Cotton (R-Arkansas) and Senator Claire McCaskill (D-Missouri) along with Senators Pat Toomey... Read More »
The PTAB held that all of Genentech’s challenged antibody purification claims were unpatentable as being anticipated, obvious, or both, in an IPR filed by... Read More »
In Polygroup Lim ited v. Willis Electric Co., Ltd., IPR2016-01613, Paper 118 (Feb. 26, 2018), the PTAB granted the patent owner Willis Electric’s motion to... Read More »
The PTAB dismissed the Saint Regis Mohawk Tribe’s attempt to avoid IPR of patents covering Restasis®, which Allergan transferred to the Tribe in a highly... Read More »
Nalco Co. v. Chem-Mod, LLC, Appeal No. 17-1036 (Fed. Cir. Feb. 27, 2018)
In Nalco Company v. Chem-Mod, LLC, the Federal Circuit reviewed the district... Read More »
Federal Circuit Summary
Before Newman, Wallach, and Chen. Appeal from the Patent Trial and Appeal Board
Summary: The Federal Circuit upheld the... Read More »
As an introduction to this topic, please reread my post of July 5, 2017 about The Cleveland Clinic v. True Health Diagnostics, subtitled “Time to Redefine... Read More »
Federal Statutes Applicable to Tribes Absent Expression to the Contrary
In addition to the state sovereign immunity dispute now headed to the Federal Circuit, you ... Read More »